286 related articles for article (PubMed ID: 21599490)
1. The solution, solid state stability and kinetic investigation in degradation studies of lercanidipine: study of excipients compatibility of lercanidipine.
Parmar N; Amin S; Singla N; Kohli K
Pharm Dev Technol; 2012; 17(6):730-40. PubMed ID: 21599490
[TBL] [Abstract][Full Text] [Related]
2. The solution and solid state stability and excipient compatibility of parthenolide in feverfew.
Jin P; Madieh S; Augsburger LL
AAPS PharmSciTech; 2007 Dec; 8(4):E105. PubMed ID: 18181526
[TBL] [Abstract][Full Text] [Related]
3. Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.
Kartal A; Björkqvist M; Lehto VP; Juppo AM; Marvola M; Sivén M
J Pharm Pharmacol; 2008 Sep; 60(9):1131-8. PubMed ID: 18718115
[TBL] [Abstract][Full Text] [Related]
4. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
Stanisz B; Regulska K; Kania J; Garbacki P
Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
[TBL] [Abstract][Full Text] [Related]
5. Surface acidity and solid-state compatibility of excipients with an acid-sensitive API: case study of atorvastatin calcium.
Govindarajan R; Landis M; Hancock B; Gatlin LA; Suryanarayanan R; Shalaev EY
AAPS PharmSciTech; 2015 Apr; 16(2):354-63. PubMed ID: 25319055
[TBL] [Abstract][Full Text] [Related]
6. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system.
Parmar N; Singla N; Amin S; Kohli K
Colloids Surf B Biointerfaces; 2011 Sep; 86(2):327-38. PubMed ID: 21550214
[TBL] [Abstract][Full Text] [Related]
7. Multitemperature stability and degradation characteristics of pergolide mesylate oral liquid.
Shank BR; Ofner CM
J Pharm Pract; 2010 Dec; 23(6):570-4. PubMed ID: 21507864
[TBL] [Abstract][Full Text] [Related]
8. The influence of pharmaceutical excipients on quinapril hydrochloride stability.
Stanisz B
Acta Pol Pharm; 2005; 62(3):189-93. PubMed ID: 16193811
[TBL] [Abstract][Full Text] [Related]
9. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
10. Stability study of flutamide in solid state and in aqueous solution.
Miranda A; Caraballo I; Millán M
Drug Dev Ind Pharm; 2002 Apr; 28(4):413-22. PubMed ID: 12056534
[TBL] [Abstract][Full Text] [Related]
11. Miniaturized approach for excipient selection during the development of oral solid dosage form.
Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
[TBL] [Abstract][Full Text] [Related]
12. Solid-state stability and compatibility studies of clavulanate potassium.
Cielecka-Piontek J; Paczkowska M; Zalewski P; Lewandowska K; Barszcz B
Pharm Dev Technol; 2015 Mar; 20(2):146-52. PubMed ID: 24219797
[TBL] [Abstract][Full Text] [Related]
13. Stability of polymorphic forms of ranitidine hydrochloride.
Wu V; Rades T; Saville DJ
Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
[TBL] [Abstract][Full Text] [Related]
14. Screening for stability and compatibility conditions of recombinant human epidermal growth factor for parenteral formulation: effect of pH, buffers, and excipients.
Santana H; González Y; Campana PT; Noda J; Amarantes O; Itri R; Beldarraín A; Páez R
Int J Pharm; 2013 Aug; 452(1-2):52-62. PubMed ID: 23624083
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of microwave oven heating for prediction of drug-excipient compatibilities and accelerated stability studies.
Schou-Pedersen AM; Østergaard J; Cornett C; Hansen SH
Int J Pharm; 2015 May; 485(1-2):97-107. PubMed ID: 25746946
[TBL] [Abstract][Full Text] [Related]
16. Pre-formulation and chemical stability studies of penethamate, a benzylpenicillin ester prodrug, in aqueous vehicles.
Jain R; Wu Z; Bork O; Tucker IG
Drug Dev Ind Pharm; 2012 Jan; 38(1):55-63. PubMed ID: 21696334
[TBL] [Abstract][Full Text] [Related]
17. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Bozdağ S; Gümüş K; Gümüş O; Unlü N
Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
[TBL] [Abstract][Full Text] [Related]
18. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
[TBL] [Abstract][Full Text] [Related]
19. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
Kristensen S; Lao YE; Brustugun J; Braenden JU
Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
[TBL] [Abstract][Full Text] [Related]
20. Investigating the Influence of Excipients on the Stability of Levothyroxine Sodium Pentahydrate.
Kaur N; Suryanarayanan R
Mol Pharm; 2021 Jul; 18(7):2683-2693. PubMed ID: 34061524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
